Adolor Investor Challenges Cubist's $415M Takeover Bid
An Adolor Corp. investor launched a class action in Delaware on Wednesday seeking to block Cubist Pharmaceuticals Inc.'s $415 million bid for the drugmaker, saying the deal was opportunistic and would...To view the full article, register now.
Already a subscriber? Click here to view full article